Cocktail Injection Improves Outcomes of FFR Guided PCI

• Status: Unknown status
• Trial end date: 2017-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a randomized, single blind, controlled study of intracoronary cocktail injection before fractional flow reserve (FFR) measurement when guiding percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Xijing Hospital
• Treatments: Bivalirudin; Tenecteplase; Tirofiban

Criteria

Inclusion Criteria:

• patients with a clinical diagnosis of recent ACS within 5 days

Exclusion Criteria:

• haemodynamic instability

• intolerance to anti-platelet drugs

• ineligible for coronary revascularization

• a treatment plan for non-coronary heart surgery (e.g. valve surgery)

• a history of prior PCI or CABG

• angiographic evidence of severe (e.g. diffuse calcification) or mild (<30% severity) coronary disease

• a life expectancy less than 1 year

• adenosine allergy